kidney disease

Original Contribution

First Clinical Experience With Targeted REnal Nerve Demodulation (TREND-1) Using a Neurotropic Agent for the Treatment of Sympathetic Hypertension

01/15/2017

Nicholas Kipshidze, MD, PhD¹; Horst Sievert, MD^2,3; Michael H. Wholey, MD, MBA⁴; Konstantin Kipiani, MD⁵; Vakhtang Kipiani, MD⁵; Tea Mukhuradze, MD⁵; Mark Wholey, MD⁶; Emily Stein, PhD⁶; K.T. Venkateswara Rao, PhD⁶

Nicholas Kipshidze, MD, PhD1; Horst ...

An evaluation of the feasibility and safety of a novel targeted neuromodulatory treatment for sympathetic hypertension involving a one-time local injection of neurotropic agents near renal nerves.

An evaluation of the feasibility...

01/15/2017

Journal of Invasive Cardiology

Original Contribution

Impact of Impaired Renal Function in Patients With Severely Calcified Coronary Lesions Treated With Orbital Atherectomy

01/15/2017

Michael S. Lee, MD¹; Evan Shlofmitz, DO²; Gentian Lluri, MD, PhD¹; Richard A. Shlofmitz, MD³

Michael S. Lee, MD1; Evan Shlofmitz,...

We evaluated the clinical outcomes of patients with chronic kidney disease who underwent orbital atherectomy for severe coronary artery calcification prior to stent implantation.

We evaluated the clinical...

01/15/2017

Journal of Invasive Cardiology